Gabapentin Oral Solution Suppliers & Bulk Manufacturers
Available Forms: Oral solution
Available Strengths: 250 mg/5 mL
Reference Brands: US: Neurontin®, Gralise®, Horizant® (ER); EU: Neurontin®, Gabantin®
Category: Antipsychotropic Drugs
Gabapentin Oral solution is available in Oral solution and strengths such as 250 mg/5 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Gabapentin Oral solution is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Gabapentin Oral solution can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Gabapentin oral solution is FDA-approved in the USA for treating partial seizures and postherpetic neuralgia. It is available as a prescription medication under the Federal Food, Drug, and Cosmetic Act, with specific guidelines for renal dose adjustment and CNS-related adverse effects. In the European Union, gabapentin is authorized via national procedures for epilepsy and neuropathic pain, with country-specific brand names and formulations. EU labeling includes warnings for CNS depression, suicidal ideation, and withdrawal symptoms. It’s classified as a prescription-only medicine (POM). To explore global availability and sourcing, visit Pharmatradz.com
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Clorazepate Dipotassium
Strength:
3.75 mg, 7.5 mg, 15 mg, 5 mg, 10 mg, 20 mg
Form: Tablets, Capsules
Reference Brands: Tranxene (USA), Tranxilium(EU)
View Details
Lumateperone
Strength:
10.5 mg, 21 mg, 42 mg
Form: Capsules
Reference Brands: Caplyta (USA)
View Details
Amoxapine
Strength:
25 mg, 50 mg, 100 mg, 150 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View Details
Amisulpride
Strength:
5 mg/2 mL, 50 mg, 100 mg, 200 mg
Form: Tablets / injectable solutions
Reference Brands: Barhemsys (USA), Solian (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
